Dose-response impact of various tocotrienols on serum lipid parameters in 5-week-old female chickens

Lipids

Volumn 41, Issue 5, 2006, Pages 453-461

  Yu, Suzanne G ^a   Thomas, Ann M ^b   Gapor, Abdul ^c   Tan, Barrie ^d   Qureshi, Nilofer ^b   Qureshi, Asaf A ^a,b  

^a Advanced Medical Research   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^c Palm Oil Research Institute of Malaysia   (Malaysia)

^d American River Nutrition Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DOSAGE; FOOD PRODUCTS; ISOMERS; LIPIDS; NUTRITION;

HDL CHOLESTEROL; HIGHER SUPPLEMENTS; SERUM TRIGLYCERIDE; TOCOTRIENOL-RICH-FRACTION (TRF);

ANIMAL CELL CULTURE;

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; CHOLESTEROL; DELTA TOCOTRIENOL; GAMMA TOCOTRIENOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYPOCHOLESTEROLEMIC AGENT; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PALM OIL; TOCOTRIENOL RICH FRACTION; UNCLASSIFIED DRUG;

AGE; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ENZYME ACTIVITY; ENZYME REGULATION; FEEDING; FEMALE; FOOD INTAKE; LIPID BLOOD LEVEL; NONHUMAN; NUTRITIONAL ASSESSMENT; RISK ASSESSMENT; TRANSCRIPTION REGULATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ALPHA-TOCOPHEROL; ANALYSIS OF VARIANCE; ANIMALS; CHICKENS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; LIPIDS; PLANT OILS; TOCOTRIENOLS; VITAMIN E;

ANIMALIA; GALLUS GALLUS;

EID: 33746941768     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-006-5119-1     Document Type: Article

References (60)

1. Ross, R. (1999) Atherosclerosis: An Inflammatory Diseases, N. Engl. J. Med. 340, 115-126.
2. Ross, R. (1993) The Pathogenesis of Atherosclerosis: A Perspective for the 1990s. Nature 362, 801-809.
3. Mehta, J.L., Saldeen, T.G.P., and Rand, K. (1998) Interactive Role of Infection, Inflammation and Traditional Risk Factors in Atherosclerosis and Coronary Artery Disease, J. Am. Coll. Cardiol. 31, 1217-1225.
4. Libby, P., and Ridker, P.M. (1999) Novel Inflammatory Markers of Coronary Risk. Theory versus Practice, Circulation 100, 1148-1150.
5. Libby, P., Hansson, G.K., and Pober, J.S. (1999) Atherogenesis and Inflammation, in Molecular Basis of Cardiovascular Disease, Chein, K.R., ed., pp. 349-366. W.B. Saunders Company, Philadelphia.
6. Ridker, P.M., Hennekens, C.H., Buring, J.E., and Rifai, N. (2000) C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women, N. Engl. J. Med. 342, 836-843.
7. Rohde, L.E.P., Hennekens, C.H., and Ridker, P.M. (1999) Survey of C-Reactive Protein and Cardiovascular Risk Factors in Apparently Healthy Men, Am. J. Cardiol. 84, 1018-1022.
8. Steinberg, D., and Lewis, A. (1997) Conner Memorial Lecture: Oxidative Modification of LDL and Atherogenesis, Circulation 95, 1062-1071.
9. Lipid Research Clinics Program. (1984) The Lipid Research Clinics Coronary Primary Prevention Trial Results. Reduction in Incidence of Coronary Heart Disease, J Am. Med. Assoc. 251, 351-354.
10. Berliner, J., Navab, M., Fogelman, A., Frank, J., Demer, L. and Edward, P. (1995) Atherosclerosis: Basic Mechanisms, Oxidation, Inflammation and Genetics, Circulation 91, 2488-2496.
11. Kita, T., Nagano, Y., Yokode, M., Ishii, K., Kume, N., Ooshima, A., Yoshida, H., and Kawai, C. (1987) Probucol Prevents the Progression of Athersclerosis in Watanabe Heritable Hyperlipidemic Rabbit, an Animal Model for Familial Hypercholesterolemia. Proc. Natl. Acad. Sci. USA 84, 5928-5931.
12. Zhang, S.H., Reddick, R.L., Avdievich, E., Surles, L.K., Jones, R.G., Reynolds, J.B., Quarfordt, S.H., and Maeda, N. (1997) Paradoxical Enhancement of Atherosclerosis by Probucol Treatment in Apolipoprotein E-Deficient Mice, J. Clin. Invest. 99, 23858-23866.
13. Brandes, R.P., Behra, A., Lebherz, C., Boger, R.H., Stefanie, M., Boger, B., and Mugge, A. (1999) Lovastatin Maintains Nitric Oxide but Not EDHF-Mediated Endothelium-Dependent Relaxation in the Hypercholesterolemic Rabbit Carotid Artery, Atherosclerosis 142, 97-104.
14. Nagano, Y., Nakamura, T., Matsuzawa, Y., Cho, M., Ueda, Y., and Kita, T. (1992) Probucol and Atherosclerosis in the Watanabe Heritable Hyperlipidemic Rabbit: Long-Term Antiatherogenic Effect and Effects on Established Plaques, Atherosclerosis 92, 131-140.
15. Sun, J., Giraud, D.W., Moxley, R.A., and Driskel, J.A. (1997) Beta-Carotene and Alpha-Tocopherol Inhibit the Development of Atherosclerotic Lesions in Hypercholesterolemic Rabbits, Int. J. Vitam. Res. 67, 155-163.
16. Nutrition Committee, American Heart Association. (1988) Dietary Guideline: Healthy American Adults. Circulation 77, 721-724A.
17. Choudhary, N., Tan, L., and Truswell, A.S. (1995) Comparison of Palmolein and Olive Oil: Effects on Plasma Lipids and Vitamin E in Young Adults, Am. J. Clin. Nutr. 61, 1043-1051.
18. Elson, C.E. (1992) Tropical Oils: Nutrition and Scientific Issues, Crit. Rev. Food Sci. Nutr. 31, 79-102.
19. Qureshi, A.A., Qureshi, N., Hasler-Rapacz, J.O., Weber, F.E., Chaudhary, V., Crenshaw, T.D., Gabor, A., Ong, A.S.H., Chong, Y.H., Peterson, D., and Rapacz, J. (1991) Dietary Tocotrienols Reduce Concentrations of Plasma Cholesterol, Apolipoprotein B, Thromboxane B2, and Platelet Factor 4 in Pigs with Inherited Hyperlipidemias, Am. J. Clin. Nutr. 53, 1042S-1046S.
20. Qureshi, A.A., Qureshi, N., Wright, J.J.K., Shen, S., Kramer, G., Gabor, A., Chong, Y.H., DeWitt, G., Ong, A.S.H., Peterson, D.M., and Bradlow, B.A. (1991) Lowering of Serum Cholesterol in Hypercholesterolemic Humans by Tocotrienols (Palmvitee). Am. J. Clin. Nutr. 53, 1021S-1026S.
21. Qureshi, N., and Qureshi, A.A. (1993) Tocotrienols, Novel Hypocholesterolemic Agents with Antioxidant Properties. In: Vitamin E in Health and Disease (Packer L, Fuchs J. eds.) pp 247-267, Mercel Dekker, Inc., New York.
22. Parker, R.A., Pearce, B.C., Clark, R.W., Gordon, D.A., and Wright, J.J.K. (1993) Tocotrienols Regulate Cholesterol Production in Mammalian Cells by Post-Transcriptional Suppression of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase, J. Biol. Chem. 268, 11230-11238.
23. Brown, M.S., and Goldstein, J.L. (1980) Multivalent Feedback Control of HMG CoA Reductase, a Control Mechanism Coordinating Isoprenoid Synthesis and Cell Growth, J. Lipid Res. 21, 505-517.
24. Ng, T.K.W., Ishak, R., Gapor, A., and Loh, C.K. (1990) Effects of Tocotrienol-Rich and Tocopherol-Rich Fractions from Palm Oil on Serum Lipids and Platelet Aggregation in the Rat, ASEAN Food J. 5, 165-169.
25. Pearce, B.C., Parker, R.A., Deason, M.E., Qureshi, A.A., and Wright, J.J.K. (1992) Hypocholesterolemic Activity of Synthetic and Natural Tocotrienols, J. Med. Chem. 35, 3595-3606.
26. Wang, L., Newman, R.K., Newman, C.W, Jackson, L.L., and Hofer, P.J. (1993) Tocotrienol and Fatty Acid Composition of Barley Oil and Their Effects on Lipid Metabolism, Plant-Foods for Human Nutrition 43, 9-17.
27. Khor, H.T., and Chieng, D.Y. (1996) Effect of Dietary Supplementation of Tocotrienols and Tocopherols on Serum Lipids in the Hamster, Nutr. Res. 16, 1391-1401.
28. Watkins, T.R., Lenz, P., Gapor, A., Struck, M., Tomeo, A., and Bierenbaum, M. (1997) γ-Tocotrienol as a Hypocholesterolemic and Antioxidant Agent in Rats Fed Atherogenic Diets, Lipids 28, 1113-1118.
29. Qureshi, A.A., Mo, H., Packer, L., and Peterson, D.M. (2000) Isolation and Structural Identification of Novel Tocotrienols from Rice Bran with Hypocholesterolemic, Antioxidant and Antitumor Properties, J. Agric. Food Chem. 48, 3130-3140.
30. U.S. Food and Drug Administration. (1978) Tocopherols and Derivatives. Proposed Affirmation of GRAS Status for Certain Tocopherols and Removal of Certain Others from GRAS Status as Direct Human Food Ingredients, Fed. Regist. 43 (209, October 27), 50193-50198.
31. Qureshi, A.A., Peterson, D.M., Hasler, R.J.-O., and Rapacz, J., (2001) Novel Tocotrienols of Rice Bran Suppress Cholesterogenesis in Hereditary Hypercholesterolemic Swine, J. Nutr. 131, 223-230.
32. Qureshi, A.A., Salser, W.A., Parmar, R., and Emeson, E.E. (2001) Novel Tocotrienols of Rice Bran Inhibit Atherosclerotic Lesions in C57BL/6 ApoE-Deficient Mice, J. Nutr. 131, 2606-2618.
33. Nakamura, H., Furukawa, F., Nishikawa, A., Miyauchi, M., Son, H.Y., Imazawa, T., and Hirose, M. (2001) Oral Toxicity of α-Tocotrienol Preparation in Rats, Food Chem. Toxicol. 39, 799-805.
34. Leveille, G.A., Romsos, D.R., Yeh, Y.Y., and O'Hea, E.K. (1975) Lipid Biosynthesis in the Chicks: A Consideration of Site of Synthesis, Influence of Diet and Possible Regulatory Mechanisms, Poultry Sci. 54, 1075-1093.
35. Shrago, E., Glennon, J.A., and Gordon, E.S. (1971) Comparative Aspects of Lipogenesis in Mammalian Tissues, Metabolism 20, 54-64.
36. Hermann, W.J.J.R., Ward, K., and Faucett, J. (1979) The Effect of Tocopherol on High Density Lipoprotein Cholesterol, a Clinical Observation, Am. J. Clin. Pathol. 72, 848-852.
37. Oriani, G., Salvatori, G., Maiorano, G., Belisasrio, M.-A., Pastinese, A., Manchisi, A., and Pizzuti, G. (1997) Vitamin E Nutritional Status and Serum Lipid Pattern in Normal Weanling Rabbits, J. Anim. Sci. 75, 402-408.
38. da Costa, V.A.V., and Vianna, L.M. (2005) Effect of Alpha-Tocopherol Supplementation on Blood Pressure and Lipidic Profile in Streptozotocin-Induced Diabetes Mellitus in Spontaneously Hypertensive Rats, Clin. Chim. Acta 351, 101-104.
39. Qureshi, A.A., Pearce, B.C., Nor, R.M., Peterson, D.M., and Elson, C.E. (1996) Dietary α-Tocopherol Attenuates the Impact of γ-Tocotrienol on Hepatic 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity in Chickens, J. Nutr. 126, 389-394.
40. Khor, H.T., and Ng, T.T. (1999) Effects of Administration of α-Tocopherol and Tocotrienols on Serum Lipid and Liver HMG-CoA Reductase Activity, Proc. PORIM Int. Palm Oil Congress (Nutr.), 177-186.
41. Tan, D.T.S., Khor, H.T., Low, W.H.S., Ali, A., and Gapor, A. (1991) The Effect of Palm Oil Vitamin E Concentrate on the Serum and Lipoprotein Lipids in Humans, Am. J. Clin. Nutr. 53, 1027S-1030S.
42. Qureshi, A.A., Bradlow, B.A., Salser, W.A., and Brace, L.D. (1997) Novel Tocotrienols of Rice Bran Modulate Cardiovascular Disease Risk Parameters of Hypercholesterolemic Humans, J. Nutr. Biochem. 8, 290-298.
43. 25) of Rice Bran and Lovastatin on Lipid Parameters in Hypercholesterolemic Humans, J. Nutr. Biochem. 12, 318-329.
44. 25) of Rice Bran in Hypercholesterolemic Humans, Atherosclerosis 161, 199-207.
45. Wahlqvist, M.L., Krivokkuca-Bogetic, Z., Lo, C.S., Hage, B., Smith, R., and Lukito, W. (1992) Different Serum Responses of Tocopherols and Tocotrienols During Vitamin E Supplementation in Hypercholesterolemic Individuals Without Change in Coronary Risk Factors, Nutr. Res. 12, S181-S201.
46. Kooyenga, D.K., Geller, M., Watkins, T.R., Gapor, A., Diakoumakis, E., and Bierenbaum, M.L. (1997) Palm Oil Antioxidant Effects in Patients with Hyperlipidaemia and Carotid Stenosis: 2-Year Experience, Asia-Pacific J. Clin Nutr. 6, 72-75.
47. Mensink, R.P., Van-Houwelingen, A.C., Kromhout, D., and Hornstra, G. (1999) A Vitamin E Concentrate Rich in Tocotrienols Had No Effect on Serum Lipids, Lipoproteins, or Platelet Function in Men with Mildly Elevated Serum Lipid Concentrations, Am. J. Clin. Nutr. 69, 213-219.
48. O'Byrne, D., Grundy, S., Packer, L., Devaraj, S., Baldenius, K., Hoppe, P.P., Kreamer, K., Jialal, I., and Traber, M.G. (2000) Studies of LDL Oxidation Following α-, γ-, or δ-Tocotrienyl Acetate Supplemention of Hypercholesterolemic Humans, Free Radical Biol. Med. 29, 834-845.
49. Mustad, V.A., Smith, C.A., Ruey, P.P., Edens, N.K., and DeMickele, S.J. (2002) Supplementation with 3 Compositionally Different Tocotrienol Supplements Does Not Improve Cardiovascular Disease Risk Factors in Men and Women with Hypercholesterolemia, Am. J. din. Nutr. 76, 1237-1243.
50. Raederstorff, D., Elste, V., Aebischer, C., and Weber, P. (2002) Effect of Either γ-Tocotrienol or α-Tocotrienol Mixture on the Plasma Lipid Profile in Hamsters, Ann. Nutr. Metabol. 46, 17-23.
51. Hayes, K.C., Pronczuk, A., and Liang, J.S. (1993) Differences in the Plasma Transport and Tissue Concentration of Tocopherols and Tocotrienols: Observations in Humans and Hamster, Proc. Soc. Exp. Biol. Med. 202, 353-360.
52. Traber, M.G., Coh, W., and Muller, D.P.R. (1993) Absorption, Transport, and Distribution to Tissues, in Vitamin E in Health and Disease, Packer, L., and Fuchs, J., eds., pp. 35-52, Marcel Dekker, Inc., New York.
53. Keyden, H.J., and Traber, M.G. (1993) Absorption, Lipoprotein Transport, and Regulation of Plasma Concentration of Vitamin E in Humans, J. Lipid Res. 34, 343-358.
54. Pearson, C.K., and Barnes, M.Mc. (1970) The Absorption and Distribution of the Naturally Occurring Tocochromanols in the Rat, Br. J. Nutr. 24, 581-587.
55. Ikeda, I., Imasato, Y., Sasaki, E., and Sugano, M. (1996) Lymphatic Transport of α-, γ-, and δ-Tocotrienols in Rats, Int. J. Vit. Nutr. Res. 66, 217-221.
56. Hosomi, A., Arita, M., Sato, Y., Kiyose, C., Ueda, T., Igarashi, O., Aria, H., Inoue, K. (1997) Affinity for α-Tocopherol Transfer Protein as a Determinant of the Biological Activities of Vitamin E Analogs, FEBS Lett. 405, 105-108.
57. Yap, S.P., Yuen, K.H., and Wong, J.W. (2001) Pharmacokinetics and Bioavailability of α-, γ-, and δ-Tocotrienols Under Different Food Status, J. Pharm. Pharmacol. 53, 67-71.
58. Khor, H.T., Chirng, D.Y., and Ong, K.K. (1995) Tocotrienols Inhibit HMG-CoA Reductase Activity in the Guinea Pig, Nutr. Res. 15, 537-544.
59. Qureshi, N., Hoffman, J., and Qureshi, A.A. (1993) Inhibition of LPS-Induced Tumor Necrosis Factor-α Synthesis and Hypocholesterolemic Effect of Novel Tocotrienols, PORIM Int. Palm Oil Congress September 20-25, N16.
60. Hasselwander, O., Kramer, K., Hoppe, P.P., Oberfrank, U., Baldenius, K., Schroder, H., Kaufmann, W., Bahnemann, R., and Nowakowsky, B. (2002) Effects of Feeding Various Tocotrienol Sources on Plasma Lipids and Aortic Atherosclerotic Lesions in Cholesterol-Fed Rabbits, Food Res. Inter. 35, 245-251.